IIIM-17/13

N/A

Report date: 2025/03/20 15:01:01
NME

Base Information

Drug NameIIIM-17/13
Drug Alias NameIL-6 antagonist (Indian Institute of Integrative Medicine)bergenin based compound (Indian Institute of Integrative Medicine)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-6 inhibitors
TargetsInterleukin-6
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIndian Institute of Integrative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesIndian Institute of Integrative Medicine
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A